Improving Clinical Trial Milestones and Reducing Site Burden with Clinical Trial Nurse Educators

Sponsored by: VMS BioMarketing
Speakers:

Kimberley M. Munn, RN, Clinical Nurse Educator, VMS BioMarketing
Karen M. Josey, Vice President, VMS BioMarketing

Wednesday - June 5, 2019 / 1:00pm ET / 10am PT
Free Event

The growing complexity of clinical trials—with intensified regulatory standards and the need to enroll highly segmented patient populations—causes delays in as many as 90% of trials. With the enormous growth in the development of specialty medicines today, manufacturers have an opportunity to utilize higher-touch, more patient-centric training initiatives in trial protocols to ensure that investigators and patients understand and administer medication properly, and to better position the product for success in the market. At the site level, the burden of the responsibilities for conducting clinical trials ends up on the shoulders of already overburdened staff. With the growing list of crucial responsibilities clinical trial site staff members oversee behind the scenes—trial management, training, regulatory compliance, data management, drug safety, recruitment, and administrative tasks—it is critical to find supportive ways to help these staff members not only train their team, but also educate the patient and caregivers.

Key takeaways

  • Identify the unmet needs of patient and site education in clinical trials
  • Provide strategies for impacting recruitment, enrollment and retention in clinical trials
  • Uncover how utilizing a Clinical Trial Nurse Educator (CTNE) can improve trial outcomes and support the patient and caregiver
  • Learn how CTNEs can help ensure patients understand what the trial is, how it works, and set the appropriate expectations up front to support enrollment and trial completion
  • Learn how CTNEs can improve accuracy and consistency of protocol implementation and reduce inter- and intra-site variability
  • Identify ways to gather actionable patient and site insights that can improve trial design, protocol compliance and inform future commercialization efforts

Who should attend:

Pharmaceutical, biotech, medical device industry and CRO leaders with responsibility for any of the following:

  • Direct to Patient Programs
  • Clinical Trial Phase I-IV operations or management
  • Clinical trial education
  • Patient, HCP and site education
  • Compliance and Adherence

About the Sponsors

VMS BioMarketing is a leading provider of patient support solutions focused on empowering healthcare providers and patients through education, training, and ongoing health coaching. For more than 20 years, VMS has been dedicated to enabling Clinical Educators to provide the personalized support necessary to help patients successfully start and stay on therapy.

For more information please visit www.vmsbiomarketing.com/.

Comments are closed.

FEEDBACK